Advertisement

Epidemiology of Cardiorenal Syndrome

  • Junior Uduman
    Correspondence
    Address correspondence to Junior Uduman, MD, Division of Nephrology, Henry Ford Hospital, 2799 West Grand Boulevard, CFP-510, Detroit, MI 48202.
    Affiliations
    Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI, and Division of Pulmonary and Critical Care Medicine, Henry Ford Hospital, Detroit, MI
    Search for articles by this author
      Cardiorenal syndrome is a spectrum of disorders that emphasizes the bidirectional nature of cardiac and kidney injury. Observational and retrospective studies have helped us to understand the prevalence and burden of each of the 5 types of cardiorenal syndromes. Cardiorenal syndrome type 1 is the most common. The nature of epidemiologic data limits clear delineation between cardiorenal syndrome types 2 and 4. Overall, the presence of cardiac or renal dysfunction strongly predicts a poor outcome of the contrary organ.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • House A.A.
        • Anand I.
        • Bellomo R.
        • et al.
        Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference.
        Nephrol Dial Transplant. 2010; 25: 1416-1420
        • Ronco C.
        • Haapio M.
        • House A.A.
        • Anavekar N.
        • Bellomo R.
        Cardiorenal syndrome.
        J Am Coll Cardiol. 2008; 52: 1527-1539
        • Ronco C.
        • Cicoira M.
        • McCullough P.A.
        Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
        J Am Coll Cardiol. 2012; 60: 1031-1042
        • Hatamizadeh P.
        • Fonarow G.C.
        • Budoff M.J.
        • Darabian S.
        • Kovesdy C.P.
        • Kalantar-Zadeh K.
        Cardiorenal syndrome: pathophysiology and potential targets for clinical management.
        Nat Rev Nephrol. 2013; 9: 99-111
        • Hill N.R.
        • Fatoba S.T.
        • Oke J.L.
        • et al.
        Global prevalence of chronic kidney disease—a systematic review and meta-analysis.
        PLoS One. 2016; 11: e0158765
        • Gheorghiade M.
        • Vaduganathan M.
        • Fonarow G.C.
        • Bonow R.O.
        Rehospitalization for heart failure: problems and perspectives.
        J Am Coll Cardiol. 2013; 61: 391-403
        • Thompson S.
        • James M.
        • Wiebe N.
        • et al.
        Cause of death in patients with reduced kidney function.
        J Am Soc Nephrol. 2015; 26: 2504-2511
        • Salim A.
        • Benouna M.E.G.
        • Habbal R.
        • El Mourid M.
        Cardiorenal syndrome type 2: a strong prognostic factor of survival.
        Int J Cardiovasc Sci. 2017; 30: 425-432
        • Cowie M.R.
        • Komajda M.
        • Murray-Thomas T.
        • Underwood J.
        • Ticho B.
        • Investigators P.
        Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH).
        Eur Heart J. 2006; 27: 1216-1222
        • Forman D.E.
        • Butler J.
        • Wang Y.
        • et al.
        Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
        J Am Coll Cardiol. 2004; 43: 61-67
        • Butler J.
        • Forman D.E.
        • Abraham W.T.
        • et al.
        Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.
        Am Heart J. 2004; 147: 331-338
        • Nohria A.
        • Hasselblad V.
        • Stebbins A.
        • et al.
        Cardiorenal interactions: insights from the ESCAPE trial.
        J Am Coll Cardiol. 2008; 51: 1268-1274
        • Weinfeld M.S.
        • Chertow G.M.
        • Stevenson L.W.
        Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure.
        Am Heart J. 1999; 138: 285-290
        • Grams M.E.
        • Astor B.C.
        • Bash L.D.
        • Matsushita K.
        • Wang Y.
        • Coresh J.
        Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.
        J Am Soc Nephrol. 2010; 21: 1757-1764
        • Blecker S.
        • Matsushita K.
        • Kottgen A.
        • et al.
        High-normal albuminuria and risk of heart failure in the community.
        Am J Kidney Dis. 2011; 58: 47-55
        • Sowers J.R.
        • Whaley-Connell A.
        • Hayden M.R.
        The role of overweight and obesity in the cardiorenal syndrome.
        Cardiorenal Med. 2011; 1: 5-12
        • Hunley T.E.
        • Ma L.J.
        • Kon V.
        Scope and mechanisms of obesity-related renal disease.
        Curr Opin Nephrol Hypertens. 2010; 19: 227-234
        • Ferris M.
        • Hogan S.L.
        • Chin H.
        • et al.
        Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study.
        Clin J Am Soc Nephrol. 2007; 2: 1207-1214
        • Aune D.
        • Sen A.
        • Norat T.
        • et al.
        Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies.
        Circulation. 2016; 133: 639-649
        • Jose P.
        • Skali H.
        • Anavekar N.
        • et al.
        Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction.
        J Am Soc Nephrol. 2006; 17: 2886-2891
        • Vardeny O.
        • Wu D.H.
        • Desai A.
        • et al.
        Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).
        J Am Coll Cardiol. 2012; 60: 2082-2089
        • Palazzuoli A.
        • Testani J.M.
        • Ruocco G.
        • Pellegrini M.
        • Ronco C.
        • Nuti R.
        Different diuretic dose and response in acute decompensated heart failure: clinical characteristics and prognostic significance.
        Int J Cardiol. 2016; 224: 213-219
        • Ellison D.H.
        • Felker G.M.
        Diuretic treatment in heart failure.
        N Engl J Med. 2017; 377: 1964-1975
        • Kellum J.A.
        • Lameire N.
        Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).
        Crit Care. 2013; 17: 204
        • Krumholz H.M.
        • Chen Y.T.
        • Vaccarino V.
        • et al.
        Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure.
        Am J Cardiol. 2000; 85: 1110-1113
        • Smith G.L.
        • Vaccarino V.
        • Kosiborod M.
        • et al.
        Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?.
        J Card Fail. 2003; 9: 13-25
        • Logeart D.
        • Tabet J.Y.
        • Hittinger L.
        • et al.
        Transient worsening of renal function during hospitalization for acute heart failure alters outcome.
        Int J Cardiol. 2008; 127: 228-232
        • Metra M.
        • Nodari S.
        • Parrinello G.
        • et al.
        Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.
        Eur J Heart Fail. 2008; 10: 188-195
        • Aronson D.
        • Burger A.J.
        The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure.
        J Card Fail. 2010; 16: 541-547
        • Verdiani V.
        • Lastrucci V.
        • Nozzoli C.
        Worsening renal function in patients hospitalized with acute heart failure: risk factors and prognostic significances.
        Int J Nephrol. 2010; 2011: 785974https://doi.org/10.4061/2011/785974
        • Hata N.
        • Yokoyama S.
        • Shinada T.
        • et al.
        Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population.
        Eur J Heart Fail. 2010; 12: 32-37
        • Kociol R.D.
        • Greiner M.A.
        • Hammill B.G.
        • et al.
        Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure.
        Am J Cardiol. 2010; 105: 1786-1793
        • Breidthardt T.
        • Socrates T.
        • Noveanu M.
        • et al.
        Effect and clinical prediction of worsening renal function in acute decompensated heart failure.
        Am J Cardiol. 2011; 107: 730-735
        • Metra M.
        • Davison B.
        • Bettari L.
        • et al.
        Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.
        Circ Heart Fail. 2012; 5: 54-62
        • Mielniczuk L.M.
        • Chandy G.
        • Stewart D.
        • et al.
        Worsening renal function and prognosis in pulmonary hypertension patients hospitalized for right heart failure.
        Congest Heart Fail. 2012; 18: 151-157
        • Roy A.K.
        • Mc Gorrian C.
        • Treacy C.
        • et al.
        A comparison of traditional and novel definitions (RIFLE, AKIN, and KDIGO) of acute kidney injury for the prediction of outcomes in acute decompensated heart failure.
        Cardiorenal Med. 2013; 3: 26-37
        • Zhou Q.
        • Zhao C.
        • Xie D.
        • et al.
        Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes.
        BMC Nephrol. 2012; 13: 51https://doi.org/10.1186/1471-2369-13-51
        • Shirakabe A.
        • Hata N.
        • Kobayashi N.
        • et al.
        Prognostic impact of acute kidney injury in patients with acute decompensated heart failure.
        Circ J. 2013; 77: 687-696
        • Li Z.
        • Cai L.
        • Liang X.
        • et al.
        Identification and predicting short-term prognosis of early cardiorenal syndrome type 1: KDIGO is superior to RIFLE or AKIN.
        PLoS One. 2014; 9: e114369
        • Shirakabe A.
        • Hata N.
        • Kobayashi N.
        • et al.
        Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure.
        ESC Heart Fail. 2018; 5: 322-331
        • Bagshaw S.M.
        • Cruz D.N.
        • Aspromonte N.
        • et al.
        Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference.
        Nephrol Dial Transplant. 2010; 25: 1406-1416
        • Ahmed A.
        • Rich M.W.
        • Sanders P.W.
        • et al.
        Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.
        Am J Cardiol. 2007; 99: 393-398
        • Gottlieb S.S.
        • Abraham W.
        • Butler J.
        • et al.
        The prognostic importance of different definitions of worsening renal function in congestive heart failure.
        J Card Fail. 2002; 8: 136-141
        • Newsome B.B.
        • Warnock D.G.
        • McClellan W.M.
        • et al.
        Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction.
        Arch Intern Med. 2008; 168: 609-616
        • Cruz D.N.
        Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes.
        Adv Chronic Kidney Dis. 2013; 20: 56-66
        • Agarwal R.
        Estimating GFR from serum creatinine concentration: pitfalls of GFR-estimating equations.
        Am J Kidney Dis. 2005; 45: 610-613
        • Claure-Del Granado R.
        • Macedo E.
        • Chertow G.M.
        • et al.
        Toward the optimal dose metric in continuous renal replacement therapy.
        Int J Artif Organs. 2012; 35: 413-424
        • Ahmad T.
        • Jackson K.
        • Rao V.S.
        • et al.
        Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury.
        Circulation. 2018; 137: 2016-2028
        • Maisel A.S.
        • Wettersten N.
        • van Veldhuisen D.J.
        • et al.
        Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: The AKINESIS Study.
        J Am Coll Cardiol. 2016; 68: 1420-1431
        • Palazzuoli A.
        • Ruocco G.
        • Beltrami M.
        • et al.
        Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
        Acute Cardiac Care. 2014; 16: 93-101
        • Alvelos M.
        • Pimentel R.
        • Pinho E.
        • et al.
        Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.
        Clin J Am Soc Nephrol: CJASN. 2011; 6: 476-481
        • Damman K.
        • Masson S.
        • Hillege H.L.
        • et al.
        Tubular damage and worsening renal function in chronic heart failure.
        JACC Heart Failure. 2013; 1: 417-424
        • Vandenberghe W.
        • Gevaert S.
        • Kellum J.A.
        • et al.
        Acute kidney injury in cardiorenal syndrome type 1 patients: a systematic review and meta-analysis.
        Cardiorenal Med. 2016; 6: 116-128
        • Damman K.
        • Navis G.
        • Voors A.A.
        • et al.
        Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.
        J Card Fail. 2007; 13: 599-608
        • Owan T.E.
        • Hodge D.O.
        • Herges R.M.
        • Jacobsen S.J.
        • Roger V.L.
        • Redfield M.M.
        Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients.
        J Card Fail. 2006; 12: 257-262
        • Damman K.
        • Valente M.A.
        • Voors A.A.
        • O'Connor C.M.
        • van Veldhuisen D.J.
        • Hillege H.L.
        Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.
        Eur Heart J. 2014; 35: 455-469
        • Parikh C.R.
        • Coca S.G.
        • Wang Y.
        • Masoudi F.A.
        • Krumholz H.M.
        Long-term prognosis of acute kidney injury after acute myocardial infarction.
        Arch Intern Med. 2008; 168: 987-995
        • Goldberg A.
        • Kogan E.
        • Hammerman H.
        • Markiewicz W.
        • Aronson D.
        The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction.
        Kidney Int. 2009; 76: 900-906
        • Anzai A.
        • Anzai T.
        • Naito K.
        • et al.
        Prognostic significance of acute kidney injury after reperfused ST-elevation myocardial infarction: synergistic acceleration of renal dysfunction and left ventricular remodeling.
        J Card Fail. 2010; 16: 381-389
        • Lassnigg A.
        • Schmidlin D.
        • Mouhieddine M.
        • et al.
        Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study.
        J Am Soc Nephrol. 2004; 15: 1597-1605
        • Chertow G.M.
        • Lazarus J.M.
        • Christiansen C.L.
        • et al.
        Preoperative renal risk stratification.
        Circulation. 1997; 95: 878-884
        • Thakar C.V.
        • Worley S.
        • Arrigain S.
        • Yared J.P.
        • Paganini E.P.
        Improved survival in acute kidney injury after cardiac surgery.
        Am J Kidney Dis. 2007; 50: 703-711
        • Thongprayoon C.
        • Cheungpasitporn W.
        • Srivali N.
        • et al.
        AKI after transcatheter or surgical aortic valve replacement.
        J Am Soc Nephrol. 2016; 27: 1854-1860
        • Kumar N.
        • Garg N.
        Acute kidney injury after aortic valve replacement in a nationally representative cohort in the USA.
        Nephrol Dial Transplant. 2018; https://doi.org/10.1093/ndt/gfy097
        • Sidney S.
        • Quesenberry Jr., C.P.
        • Jaffe M.G.
        • et al.
        Recent trends in cardiovascular mortality in the United States and public Health goals.
        JAMA Cardiol. 2016; 1: 594-599
        • McCullough P.A.
        • Philbin E.F.
        • Spertus J.A.
        • Kaatz S.
        • Sandberg K.R.
        • Weaver W.D.
        Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.
        J Am Coll Cardiol. 2002; 39: 60-69
        • Hebert K.
        • Dias A.
        • Delgado M.C.
        • et al.
        Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population.
        Eur J Heart Fail. 2010; 12: 861-865
        • Dries D.L.
        • Exner D.V.
        • Domanski M.J.
        • Greenberg B.
        • Stevenson L.W.
        The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.
        J Am Coll Cardiol. 2000; 35: 681-689
        • Shlipak M.G.
        • Smith G.L.
        • Rathore S.S.
        • Massie B.M.
        • Krumholz H.M.
        Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.
        J Am Soc Nephrol. 2004; 15: 2195-2203
        • Heywood J.T.
        • Fonarow G.C.
        • Costanzo M.R.
        • et al.
        High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.
        J Card Fail. 2007; 13: 422-430
        • Elsayed E.F.
        • Tighiouart H.
        • Griffith J.
        • et al.
        Cardiovascular disease and subsequent kidney disease.
        Arch Intern Med. 2007; 167: 1130-1136
        • Rose E.A.
        • Gelijns A.C.
        • Moskowitz A.J.
        • et al.
        Long-term use of a left ventricular assist device for end-stage heart failure.
        N Engl J Med. 2001; 345: 1435-1443
        • Tromp T.R.
        • de Jonge N.
        • Joles J.A.
        Left ventricular assist devices: a kidney's perspective.
        Heart Fail Rev. 2015; 20: 519-532
        • Kirklin J.K.
        • Naftel D.C.
        • Kormos R.L.
        • et al.
        Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant.
        J Heart Lung Transplant. 2013; 32: 1205-1213
        • Sandner S.E.
        • Zimpfer D.
        • Zrunek P.
        • et al.
        Renal function and outcome after continuous flow left ventricular assist device implantation.
        Ann Thorac Surg. 2009; 87: 1072-1078
        • Iwashima Y.
        • Yanase M.
        • Horio T.
        • et al.
        Serial changes in renal function as a prognostic indicator in advanced heart failure patients with left ventricular assist system.
        Ann Thorac Surg. 2012; 93: 816-823
        • Hoste E.A.
        • Bagshaw S.M.
        • Bellomo R.
        • et al.
        Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.
        Intensive Care Med. 2015; 41: 1411-1423
        • Mehta R.L.
        • Pascual M.T.
        • Soroko S.
        • et al.
        Spectrum of acute renal failure in the intensive care unit: the PICARD experience.
        Kidney Int. 2004; 66: 1613-1621
        • Wu V.C.
        • Wu C.H.
        • Huang T.M.
        • et al.
        Long-term risk of coronary events after AKI.
        J Am Soc Nephrol. 2014; 25: 595-605
        • Odutayo A.
        • Wong C.X.
        • Farkouh M.
        • et al.
        AKI and long-term risk for cardiovascular events and mortality.
        J Am Soc Nephrol. 2017; 28: 377-387
        • Bouchard J.
        • Soroko S.B.
        • Chertow G.M.
        • et al.
        Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury.
        Kidney Int. 2009; 76: 422-427
        • Foley R.N.
        • Murray A.M.
        • Li S.
        • et al.
        Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
        J Am Soc Nephrol. 2005; 16: 489-495
        • Cheung A.K.
        • Sarnak M.J.
        • Yan G.
        • et al.
        Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.
        Kidney Int. 2004; 65: 2380-2389
        • Shlipak M.G.
        • Fried L.F.
        • Cushman M.
        • et al.
        Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.
        JAMA. 2005; 293: 1737-1745
        • Gerstein H.C.
        • Mann J.F.
        • Yi Q.
        • et al.
        Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
        JAMA. 2001; 286: 421-426
        • Wachtell K.
        • Ibsen H.
        • Olsen M.H.
        • et al.
        Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
        Ann Intern Med. 2003; 139: 901-906
        • Ibsen H.
        • Olsen M.H.
        • Wachtell K.
        • et al.
        Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
        Hypertension. 2005; 45: 198-202
        • Klausen K.
        • Borch-Johnsen K.
        • Feldt-Rasmussen B.
        • et al.
        Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes.
        Circulation. 2004; 110: 32-35
        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • McCulloch C.E.
        • Hsu C.Y.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N Engl J Med. 2004; 351: 1296-1305
        • Anavekar N.S.
        • McMurray J.J.
        • Velazquez E.J.
        • et al.
        Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
        N Engl J Med. 2004; 351: 1285-1295
        • Hillege H.L.
        • Girbes A.R.
        • de Kam P.J.
        • et al.
        Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
        Circulation. 2000; 102: 203-210
        • Kotecha A.
        • Vallabhajosyula S.
        • Coville H.H.
        • Kashani K.
        Cardiorenal syndrome in sepsis: a narrative review.
        J Crit Care. 2018; 43: 122-127
        • Vallabhajosyula S.
        • Sakhuja A.
        • Geske J.B.
        • et al.
        Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: an eight-year cohort study.
        PLoS One. 2018; 13: e0190965